Johnson & Johnson (JNJ) is the most durable income generator on this list, with 62+ consecutive years of dividend increases. Its diversified pharmaceutical and medical device operations generate over $20 billion in annual free cash flow, comfortably supporting a 3% yield. This cash flow strength outperforms #2 Procter & Gamble's $15 billion free cash flow, offering greater reinvestment capacity. JNJ's payout ratio of roughly 45% ensures ample room for future growth, making it a top pick for long-term reliability.

Comments on "Johnson & Johnson (JNJ)"
Create a free account or sign in to join the discussion.
Sign in to join the conversation